The contribution of cognition and spasticity to driving performance in multiple sclerosis.
about
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosisShock waves in the treatment of muscle hypertonia and dystonia.Driving assessment and rehabilitation using a driving simulator in individuals with traumatic brain injury: A scoping review.Assessing executive function in relation to fitness to drive: a review of tools and their ability to predict safe driving.Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review.Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening batteryResource consumption and simulator driving performance using adaptive controls.Predictors of driving in individuals with relapsing-remitting multiple sclerosis.Neuropsychological Functioning in Veterans with Posttraumatic Stress Disorder: Associations with Performance Validity, Comorbidities, and Functional Outcomes.Prediction of driving ability in people with relapsing-remitting multiple sclerosis using the stroke driver screening assessment.Driving performance in persons with mild to moderate symptoms of multiple sclerosis.Comparison of foot pedal reaction time among patients with right or left hemiplegia and able-bodied controls.Drug-resistant MS spasticity treatment with Sativex(®) add-on and driving ability.On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: A prospective study.Prospective memory while driving: comparison of time- and event-based intentions.The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity.
P2860
Q26770823-8E9B9CBB-29FA-4362-AF5A-317B1AE7C24EQ30428617-01E24294-6380-41FD-8B45-8ED311C0A639Q36066727-A272CC7B-D4F1-4EBB-93DF-BAE57A7BF79EQ38061738-B25597FB-747C-4DF0-978B-9BBCA2DA7E1BQ38183817-AB3EA7A8-88C9-49E5-AEED-F7EA7D47EFC4Q38427137-5AC81F17-886D-4DEE-A256-7DF79DF01574Q39353001-65F40093-58BE-47AC-91FF-E87BFA898097Q39592149-763E64EA-32F8-4989-9420-81E18B6EA3C2Q40900691-643D04A8-A6F9-43B1-BEF5-901F2402A8CCQ41854948-50A90061-1D2B-4624-9095-AE4A183A626FQ44121336-55BD0DAB-6406-415A-8E6B-B4F3F5C26D4DQ45211551-DBD7ABBF-8E7E-4F29-8D0B-6FA08F5AA3C0Q45824130-CFD19136-6C8F-4816-98BB-69FF62ADF599Q50569296-DE9CD57E-CC34-49C1-A7D1-E82062061B71Q50635572-D4B9A2CC-2F1F-441B-A19F-60AA3D0A62B7Q55025049-A423FE7F-F91E-4CF7-9F94-6429132E5861
P2860
The contribution of cognition and spasticity to driving performance in multiple sclerosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The contribution of cognition ...... ormance in multiple sclerosis.
@ast
The contribution of cognition ...... ormance in multiple sclerosis.
@en
type
label
The contribution of cognition ...... ormance in multiple sclerosis.
@ast
The contribution of cognition ...... ormance in multiple sclerosis.
@en
prefLabel
The contribution of cognition ...... ormance in multiple sclerosis.
@ast
The contribution of cognition ...... ormance in multiple sclerosis.
@en
P2093
P2860
P1476
The contribution of cognition ...... ormance in multiple sclerosis.
@en
P2093
Erica Roberts
J Cobb Scott
Jody Corey-Bloom
R Wade Allen
Sara Lampinen
Theodore J Rosenthal
Thomas D Marcotte
P2860
P304
P356
10.1016/J.APMR.2007.12.049
P577
2008-09-01T00:00:00Z